You’re doing the work. You’re eating reasonably well, exercising when you can, managing a full life — and still, something feels off. Your energy isn’t what it was. Your sleep is broken. Your body is changing in ways that don’t feel like normal aging.
Your metabolic terrain is no longer supporting the hormonal output your body needs to perform.
Specifically, leptin resistance and insulin resistance — two interconnected disruptions in how your body regulates energy, hunger, and cellular signaling — are quietly accelerating hormonal decline and biological aging in women. And they’re being driven by four modifiable factors: cortisol load, sleep disruption, chronic inflammation, and gut dysfunction.
THE METABOLIC FOUNDATION: LEPTIN AND INSULIN RESISTANCE IN WOMEN
Before we get to what you can control, you need to understand what’s being disrupted.
Leptin is the hormone that tells your brain you have enough energy — it suppresses appetite, boosts metabolism, and regulates reproductive and thyroid function. Women naturally have higher circulating leptin levels than men at any given level of body fat — a pattern researchers describe as consistent with a higher leptin “set point,” and in some cases, relative leptin resistance. When that resistance develops, the brain fails to register the body’s energy surplus: it doesn’t receive the signal clearly, so appetite suppression weakens, metabolism slows, and fat storage is prioritized — even in the absence of an energy deficit.
Insulin resistance compounds this. When cells stop responding to insulin efficiently, blood sugar dysregulation follows — along with elevated triglycerides, low HDL, increased visceral fat, and higher cardiovascular risk. Women are protected from insulin resistance before menopause largely because of estrogen. When estrogen drops, that protection disappears. Visceral fat accumulates. Insulin sensitivity worsens. And the metabolic terrain shifts under your feet.
Here’s what makes this particularly relevant for hormonal health: leptin and insulin resistance don’t just affect weight and energy. They actively disrupt the hormonal axes that govern your reproductive function, thyroid, adrenal output, and rate of biological aging.
HOW THIS DISRUPTS HORMONAL REGULATION
Your reproductive axis (HPG axis):
Hyperinsulinemia — chronically elevated insulin — stimulates the ovaries to overproduce androgens, lowers SHBG, and increases free testosterone. This is the core mechanism behind PMOS, but it doesn’t stop there. It disrupts ovulation, menstrual regularity, and hormonal rhythm at any life stage. Meanwhile, leptin plays a gating role in the HPG axis: when leptin drops too low (from crash dieting, undereating, or functional deficiency), GnRH pulsatility suppresses and cycles go offline entirely.
Your thyroid axis (HPT axis):
Leptin is required to maintain TRH expression — the signal that drives TSH and thyroid hormone production. In states of functional leptin resistance or deficiency, thyroid output drops. Emerging research suggests that in women with obesity and insulin resistance, thyroid function may be partially impaired at the level of hormone biosynthesis and utilization — not just the gland itself. The relationship is bidirectional and still being characterized, but the clinical implication is meaningful: optimizing metabolic terrain is part of thyroid support, not separate from it.
Your adrenal axis (HPA axis):
There is a direct antagonism between cortisol and leptin. As cortisol rises, leptin effectiveness falls. This creates a neuroendocrine pattern that resembles starvation — the brain reads the body as energy-depleted and responds accordingly: appetite up, metabolism down, fat storage prioritized. In high-performing women carrying significant stress loads, this cycle runs silently in the background, compounding hormonal dysfunction year after year.
HOW THIS ACCELERATES AGING
This isn’t just about how you feel today. Insulin resistance is associated with accelerated epigenetic aging — measurable changes in DNA methylation patterns that indicate your cells are aging faster than your chronological years. It’s linked to telomere shortening, increased senescent T-cells, and chronic low-grade inflammation that drives oxidative stress at the cellular level.
The menopausal transition is the inflection point. The convergence of estrogen withdrawal, worsening insulin resistance, and progressive leptin resistance during perimenopause creates a compounding metabolic deterioration — not just weight changes, but accelerated cardiovascular risk, cognitive vulnerability, and inflammatory burden. Early menopause (before 45) is associated with a 20% higher incidence of type 2 diabetes. A reproductive lifespan of less than 30 years confers a 37% higher risk.
These aren’t inevitable outcomes. They’re the result of a terrain left unsupported.
THE 4 MODIFIABLE FACTORS DRIVING THE LOAD
You cannot supplement your way out of a dysregulated terrain. But you can systematically reduce the inputs that are driving leptin and insulin resistance — and four of them are within your direct control.
1. CORTISOL LOAD
Chronic stress isn’t just exhausting — it’s metabolically disruptive. Cortisol is an insulin antagonist: chronic elevation is associated with higher fasting glucose and impaired insulin sensitivity — with adiposity playing a contributing role in that relationship. In women with obesity, there’s a measurable leptin-cortisol antagonism — as cortisol rises, leptin effectiveness drops, creating what researchers describe as a “neuroendocrine starvation” response. Your brain reads stress as famine. And it responds accordingly.
Sex hormones shape HPA axis regulation differently in women and men — estrogen may offer some premenopausal protection, while androgens influence stress-related fat distribution differently in men. The picture is complex, but what’s consistent is this: the high-performing woman carrying sustained psychological and physiological stress loads is often running a cortisol pattern that is silently dismantling her hormonal function — while her labs look “normal.”
What moves the needle: cognitive behavioral therapy, structured relaxation, and HPA axis repair — not stress “management” as a buzzword, but targeted nervous system down-regulation as a clinical intervention.
2. SLEEP DISRUPTION
Six weeks of sleeping 6.2 hours per night — not dramatically short, just a little less than recommended — significantly increased fasting insulin and insulin resistance in women. In postmenopausal women, the effect was nearly double that seen in premenopausal women. These changes were independent of body fat. Sleep deprivation simultaneously drops leptin and raises ghrelin, increasing hunger and appetite for calorie-dense foods — compounding leptin resistance over time. Short sleep also elevates evening cortisol, feeding directly into the cortisol-leptin antagonism described above.
Seven to nine hours of sleep per night isn’t a lifestyle aspiration. It’s a metabolic intervention. Research has associated chronic short sleep — six hours or less — with significantly elevated odds of impaired fasting glucose, though the effect size varies across studies and is partly influenced by adiposity.
3. CHRONIC INFLAMMATION
Inflammation is the mechanistic bridge between leptin resistance and insulin resistance. Pro-inflammatory cytokines — TNF-α, IL-6, IL-1β — activate signaling pathways that impair both insulin receptor function and the brain’s ability to respond to leptin. This creates a self-reinforcing cycle: metabolic dysfunction drives inflammation, inflammation deepens metabolic dysfunction.
Obesity-driven leptin resistance and insulin resistance both elevate CRP, TNF-α, and IL-6 — markers associated with oxidative stress, telomere attrition, and accelerated cellular aging. The anti-inflammatory levers that matter most: omega-3 fatty acid intake, polyphenol-rich foods, elimination of ultra-processed foods, and moderate-intensity exercise. These aren’t adjunctive “nice to haves” — they are terrain interventions.
4. GUT DYSFUNCTION
The gut is a metabolic organ, not just a digestive one. Decreased microbial diversity is directly associated with higher serum leptin and increased insulin resistance. In metabolic dysfunction, increased gut permeability allows microbial components to enter systemic circulation, inhibiting leptin signaling and driving inflammation. Dysbiosis drives dysglycemia.
The primary modifiable lever is dietary fiber — specifically the kind that feeds butyrate-producing bacteria (Faecalibacterium, Butyrivibrio). Butyrate improves glucose homeostasis and is inversely associated with type 2 diabetes risk. Prebiotic fiber increases GLP-1 and PYY (satiety hormones) while suppressing ghrelin — directly supporting leptin signaling. A diverse, fiber-rich, anti-inflammatory diet restructures the gut toward saccharolytic fermentation and away from the proteolytic patterns that generate inflammatory metabolites.
THIS IS WHAT THE FORGOTTEN HORMONES PROGRAM ADDRESSES
Instead of only treating the outputs — the symptoms, the labs, the individual markers — consider also addressing the terrain producing the outputs. This is how our Forgotten Hormones program is built.
It is a 6-week group program is designed for high-performing women who are done managing symptoms and ready to address the biology underneath them.
The program works across six foundational areas — including HPA axis repair, circadian rhythm restoration, gut optimization, detox pathways, nutrition, and exercise protocol — building the metabolic terrain that allows your hormones to actually function the way they’re designed to.
When your terrain is balanced, your insulin and leptin are better managed, and we consistently see patients needing less direct hormonal therapy.
Check out the Forgotten Hormones Program here